Center for Cell Neurobiology and Neurodegeneration Research, University of Massachusetts, Lowell, Lowell MA 01854, USA.
J Nutr Health Aging. 2010 Mar;14(3):224-30. doi: 10.1007/s12603-010-0054-5.
Adults of both genders without dementia consumed a nutriceutical formulation ("NF," consisting of folic acid, B12, Vitamin E, S-adenosylmethionine, N-acetyl cysteine and Acetyl-L-carnitine), previously shown to improve cognitive performance in Alzheimer's disease, or placebo. Participants receiving NF but not placebo improved statistically and clinically in the California Verbal Learning Test II and the Trail-Making Test. Both groups improved further during a 3-month open-label extension. Additional individuals displayed identical improvement during a separate 6-month open-label trial. Performance declined to baseline following withdrawal of NF, and statistically improved when participants resumed taking NF. Additional participants receiving NF but not placebo demonstrated improvement within 2 weeks in Trail-making and Digit-Memory tests; both groups improved in a 2-week open-label extension. An increased percentage of participants > or = 74 years of age did not show improvement with NF, which may relate to age-related difficulties in adsorption and/or basal nutritional deficiencies, or age-related cognitive decline during the course of this study. These findings support the benefit of nutritional supplements for cognitive performance and suggest that additional supplementation may be required for the elderly.
两性成年人,无痴呆症,食用营养制剂(“NF”,由叶酸、B12、维生素 E、S-腺苷甲硫氨酸、N-乙酰半胱氨酸和乙酰左旋肉碱组成),先前已被证明可改善阿尔茨海默病患者的认知功能,或安慰剂。接受 NF 的参与者而非安慰剂组在加利福尼亚词语学习测试 II 和连线测试中在统计学和临床上都有所改善。两组在为期 3 个月的开放标签扩展期内进一步改善。在另一项单独的 6 个月开放标签试验中,其他参与者表现出相同的改善。停止使用 NF 后,表现恢复到基线,当参与者重新开始服用 NF 时,表现显著改善。接受 NF 的其他参与者在 2 周内的连线测试和数字记忆测试中表现出改善;两组在 2 周的开放标签扩展期内都有改善。更多年龄在 74 岁及以上的参与者没有显示出 NF 的改善,这可能与年龄相关的吸收困难和/或基础营养缺乏有关,或与研究过程中年龄相关的认知能力下降有关。这些发现支持营养补充剂对认知功能的益处,并表明老年人可能需要额外的补充。